Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting

被引：0
作者：
Lubrano, E. [1 ]
Scriffignano, S. [1 ]
De Socio, A. [1 ]
Perrotta, F. M. [1 ]
机构：
[1] Univ Molise, Dipartimento Med & Sci Salute Vincenzo Tiberio, Acad Rheumatol Unit, Via Giovanni Paolo II, I-86100 Campobasso, Italy
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2019年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [31] Therapeutic strategies utilization and resource consumption in patients treated for psoriatic arthritis: findings from a real-world analysis in an Italian setting
    Esposti, L. Degli
    Perrone, V.
    Sangiorgi, D.
    Alessandrini, D.
    Buda, S.
    Cantini, F.
    Mazzini, E.
    Toma, C.
    De Solda, F.
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 187 - 194
  • [32] Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study
    Lampropoulos, C. E.
    Orfanos, P.
    Manoussakis, M. N.
    Tzioufas, A. G.
    Moutsopoulos, H. M.
    Vlachoyiannopoulos, P. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (02) : 192 - 200
  • [33] Treat-to-Target Strategy Implementation in Spondyloarthritis Patients of Real-World Clinical Practice: A Cross-Sectional Single-Center Study
    Flouri, Irini
    Avgoustidis, Nestor
    Eskitzis, Anastasios
    Repa, Argyro
    Pateromichelaki, Katerina
    Pitsigavdaki, Sofia
    Nikoloudaki, Myrto
    Terizaki, Maria
    Bertsias, George
    Sidiropoulos, Prodromos
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1063 - 1064
  • [34] Is there a reduction in hip destruction under a treat-to-target strategy in patients with rheumatoid arthritis?
    Tsushima, Hidetoshi
    Takahide, Sakuragi
    Akasaki, Yukio
    Fujiwara, Toshifumi
    Hara, Daisuke
    Ikemura, Satoshi
    Sakuraba, Kouji
    Kamura, Satoshi
    Miyahara, Hisaaki
    Yamada, Hisakata
    Fukushi, Jun-ichi
    Nakashima, Yasuharu
    MODERN RHEUMATOLOGY, 2024, 34 (02) : 334 - 339
  • [35] Predictors of Response in Patients with Psoriatic Arthritis Treated with Anti-TNF in a Real-World Setting
    Sholter, Dalton
    Kelsall, John
    Arendse, Regan
    Avina-Zubieta, Antonio
    Bensen, William
    Zummer, Michel
    Faraawi, Rafat
    Dixit, Sanjay
    Khraishi, Majed
    Fortin, Isabelle
    Sampalis, John
    Psaradellis, Eliofotisti
    Nantel, Francois
    Shawi, May
    Otawa, Susan
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1347 - 1347
  • [36] PREDICTORS OF RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH ANTI-TNF IN A REAL-WORLD SETTING
    Sholter, D.
    Kelsall, J.
    Arendse, R.
    Avina-Zubieta, A.
    Bensen, W.
    Zummer, M.
    Faraawi, R.
    Dixit, S.
    Khraishi, M.
    Fortin, I.
    Sampalis, J.
    Psaradellis, E.
    Nantel, F.
    Tkaczyk, C.
    Lehman, A. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 861 - 862
  • [37] INITIAL EVIDENCE FOR THE NEED OF A DUAL TREAT-TO-TARGET STRATEGY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Oppenauer, Claudia
    Durechova, Martina
    Zauner, Michael
    Posch, Martin
    Urach, Susanne
    Machold, Klaus
    Aletaha, Daniel
    Ferreira, Ricardo
    Stamm, Tanja
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1118 - 1119
  • [38] 5 YEARS FOLLOW-UP OF PSORIATIC ARTHRITIS PATIENTS TREATED ACCORDING TREAT-TO-TARGET STRATEGY. PRELIMINARY RESULTS
    Tremaskina, P.
    Loginova, E.
    Korotaeva, T.
    Glukhova, S.
    Lila, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1306 - 1306
  • [39] Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis - real-world evidence from Germany
    Papukchieva, Steffeni
    Stratil, Ann-Sophie
    Kahn, Maria
    Ness, Nils-Henning
    Hollnagel-Schmitz, Maike
    Gerencser, Vivien
    Rustemeier, Julia
    Eberl, Markus
    Friedrich, Benjamin
    Ziemssen, Tjalf
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [40] Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy
    ten Klooster, Peter M.
    Voshaar, Martijn A. H. Oude
    Fakhouri, Walid
    de la Torre, Inmaculada
    Nicolay, Claudia
    van de Laar, Mart A. F. J.
    CLINICAL RHEUMATOLOGY, 2019, 38 (10) : 2727 - 2736
12345